4processed
Form 4 — Insider Transaction
BridgeBio Pharma, Inc.(BBIO)
Filing Date
May 16, 2026
Accepted
May 16, 2026
Accession No.
0001470831-26-000472
CIK
0001743881
Insider Transactions
| Insider | Title | Type | Shares | Price | Value | Owned After | Security | Date |
|---|---|---|---|---|---|---|---|---|
| Kumar Neil | Chief Executive Officer | Other | 33.5K | — | — | 268.0K | Common Stock | May 16, 2026 |
| Kumar Neil | Chief Executive Officer | Other | 19.6K | — | — | 287.6K | Common Stock | May 16, 2026 |
| Kumar Neil | Chief Executive Officer | Other | 11.6K | — | — | 299.1K | Common Stock | May 16, 2026 |
| Kumar Neil | Chief Executive Officer | Other | 6.5K | — | — | 305.7K | Common Stock | May 16, 2026 |
| Kumar Neil | Chief Executive Officer | Other | 36.2K | $66.13 | — | 269.4K | Common Stock | May 16, 2026 |
| Kumar Neil | Chief Executive Officer | Other | 33.5K | $0 | — | 100.6K | Restricted Stock Units | May 16, 2026 |
| Kumar Neil | Chief Executive Officer | Other | 19.6K | $0 | — | 137.2K | Restricted Stock Units | May 16, 2026 |
| Kumar Neil | Chief Executive Officer | Other | 11.6K | $0 | — | 127.1K | Restricted Stock Units | May 16, 2026 |
| Kumar Neil | Chief Executive Officer | Other | 6.5K | $0 | — | 97.8K | Restricted Stock Units | May 16, 2026 |